Protalix BioTherapeutics/$PLX
About Protalix BioTherapeutics
Ticker
Trading on
Industry
Headquarters
Employees
PLX Metrics
$175M
-
-$0.13
0.71
-
Price and volume
Market cap
$175M
Beta
0.71
52-week high
$2.54
52-week low
$0.82
Average daily volume
568K
Financial strength
Current ratio
1.976
Quick ratio
1.222
Long term debt to equity
12.874
Total debt to equity
17.523
Interest coverage (TTM)
-4.87%
Management effectiveness
Return on assets (TTM)
-7.47%
Return on equity (TTM)
-27.18%
Valuation
Price to revenue (TTM)
3.795
Price to book
5.38
Price to tangible book (TTM)
5.38
Price to free cash flow (TTM)
24.169
Growth
Revenue change (TTM)
-28.22%
Earnings per share change (TTM)
-205.73%
3-year revenue growth (CAGR)
-2.52%
3-year earnings per share growth (CAGR)
-35.89%
What the Analysts think about PLX
Analyst Ratings
PLX Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
PLX Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
PLX News
What’s the current market cap for Protalix BioTherapeutics stock?
What is the P/E ratio for Protalix BioTherapeutics stock?
Does Protalix BioTherapeutics stock pay dividends?
No, Protalix BioTherapeutics (PLX) stock does not pay dividends to its shareholders as of January 31, 2025.
When is the next Protalix BioTherapeutics dividend payment date?
Protalix BioTherapeutics (PLX) stock does not pay dividends to its shareholders.
What is the beta indicator for Protalix BioTherapeutics?
Protalix BioTherapeutics (PLX) has a beta rating of 0.71. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.